Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › ArylSulfonamide-based matrix metalloprotease inhibitors

ArylSulfonamide-based matrix metalloprotease inhibitors

US Patent 9822092 · Granted Nov 21, 2017

Estimated economic value: $37,877,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-azaspiro[3.4]octane derivatives as M4 agonists2024
2-azaspiro[3.4]octane derivatives as M4 agonists2023
Pyrazolyl derivatives useful as anti-cancer agents2023
2-azaspiro[3.4]octane derivatives as M4 agonists2023
2-azaspiro[3.4]octane derivatives as M4 agonists2022
Compounds and methods for treating bacterial infections2021
Compounds and compositions for inhibiting the activity of SHP22021
Beta-lactamase inhibitor compounds2020
Combination therapy for treatment of resistant bacterial infections2019
Compounds and compositions for inhibiting the activity of SHP22019
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH2018
4-piperidinyl compounds for use as tankyrase inhibitors2018